Pharma 5’s Research and Development unit is completely independent from other activities with significant human and material resources that are totally dedicated.
Equipped with cutting-edge technology and a high-performance management team, this unit enables Pharma 5 to consolidate its leadership position and to map out the company’s development prospects.
More than 95% of the medicines manufactured by Pharma 5 laboratories are designed and developed within its own Research and Development unit, in compliance with the most demanding quality standards (GMP1, WHO2, ICH3 and EDQM4 standards).
Our independence in mastering this strategic know-how allows us to differentiate ourselves by responding to patient needs with responsiveness, efficiency and safety, particularly in the case of Public Health issues. For example, Pharma 5 has developed tuberculosis drugs for which we hold international patents.
1. GMP: Good Manufacturing Practices | 2. WHO: World Health Organization | 3. ICH: International Conference on Harmonization of Technical Requirements for Registration of Medicinal Products for Human Use | 4. EDQM: European Directorate for the Quality of Medicines